IDXX Q3 2021 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$810M+12.3% YoY

Gross Profit

$473M58.4% margin

Operating Income

$226M27.9% margin

Net Income

$175M21.6% margin

EPS (Diluted)

$2.03

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

$187M

Free Cash Flow

$142M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.6B

Stockholders' Equity

$755M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$810M	$722M	+12.3%
Gross Profit	$473M	$423M	+11.9%
Operating Income	$226M	$172M	+31.5%
Net Income	$175M	$146M	+19.8%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$2.7B98%

Reagent Rental Programs

$39M1%

Extended Warranties And Post Contract Support

$17M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$514M63%

EMEA

$168M21%

Asia Pacific

$78M10%

CANADA

$33M4%

Latin America

$17M2%